Showing 2,662 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

Is a simple sofosbuvir plus ribavirin regimen suitable for difficult-to-treat hepatitis C patients?

News
12 December 2012
Hepatitis & HIV

HIV and hepatitis C co-infection increases the risk of cognitive impairment

News
11 December 2012
Pharmaceutical industry

Copy of ITPC Open letter from activists in EECA about the Galien Prix Award goint to Merck for boceprevir

Editor's pick
GMI Partnership
6 December 2012
Pharmaceutical industry

ITPC Open letter from activists in EECA about the Galien Prix Award goint to Merck for boceprevir

Editor's pick
EATG
6 December 2012
Side effects

Copy of Liver toxicity uncommon with modern antiretroviral drugs, but higher risk for HIV/HCV coinfected

Editor's pick
HIVandHepatitis.com
6 December 2012
Side effects

Liver toxicity uncommon with modern antiretroviral drugs, but higher risk for HIV/HCV coinfected

Editor's pick
HIVandHepatitis.com
6 December 2012
New & experimental hepatitis C treatment

Hepatitis C patients with cirrhosis respond well to boceprevir or telaprevir with careful monitoring

News
5 December 2012
Cancer

Brivanib fails to match sorafenib for liver cancer, but tivantinib looks promising

News
5 December 2012
New & experimental hepatitis C treatment

Monoclonal antibody GS-6624 well tolerated by patients with hepatic fibrosis in initial safety study

Editor's pick
Healio Hepatology
4 December 2012
New & experimental hepatitis C treatment

Telaprevir and VX-222 pair well in interferon-free regimen, VX-135 on the horizon

News
3 December 2012
Hepatitis C transmission & prevention

Medical Technician Accused in Hepatitis C Infections Is Indicted on New Charges

Editor's pick
New York Times
3 December 2012
Hepatitis B

Nucleoside analogues reduce hepatitis B liver cancer risk

News
29 November 2012
HIV treatment for children & young people

Copy of European Commission approves Viread ® for HIV-1 infection in children and adolescents and for chronic hepatitis B in adolescents

Editor's pick
Gilead press release
28 November 2012
HIV treatment for children & young people

European Commission approves Viread ® for HIV-1 infection in children and adolescents and for chronic hepatitis B in adolescents

Editor's pick
Gilead press release
28 November 2012
Hepatitis C treatment

Hepatitis C Reaching Crisis Levels; Requires Coverage for Routine Screenings

Editor's pick
National Summit on HIV and Viral Hepatitis press release
28 November 2012
New & experimental hepatitis C treatment

Gilead Announces Sustained Virologic Response Rate of 78% From Phase 3 Study of Sofosbuvir for Genotype 2/3 Hepatitis C Infected Patients

Editor's pick
Gilead press release
27 November 2012
Hepatitis C symptoms & diagnosis

Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement

Editor's pick
US Preventive Services Task Force
27 November 2012
Hepatitis C symptoms & diagnosis

Less Support for Hepatitis C Testing for Baby Boomers

Editor's pick
New York Times
27 November 2012
Hepatitis C symptoms & diagnosis

Screening for Hepatitis C Virus Infection in Adults: A Systematic Review

Editor's pick
US Preventive Services Task Force
27 November 2012
Hepatitis C symptoms & diagnosis

HCV Screening Benefit Still Uncertain

Editor's pick
MedPage Today
27 November 2012
Hepatitis C transmission & prevention

Sharing drug preparation equipment a potential source of hepatitis C transmission

News
27 November 2012
Hepatitis C treatment

Devon Nicholson Hep C treatment Chronicles – Week 4 – “Blood Work and Virus Tests"

Editor's pick
Net Newsledger
26 November 2012
Hepatitis C treatment

Telaprevir twice-daily works as well as every eight hours, safe for hepatitis C patients with cirrhosis

News
23 November 2012
Hepatitis C treatment

Which patients should be prioritised for new hepatitis C treatments?

News
23 November 2012